The antimicrobial resistance containment and surveillance approach--a public health tool

Gunnar S Simonsen1, John W Tapsall, Benedetta Allegranzi

  • 1Norwegian Surveillance System for Antimicrobial Drug Resistance (NORM), Department of Microbiology, University Hospital of North Norway, N-9038 Tromsø, Norway.

Insights

Antimicrobial drug resistance (AMR) is a global health threat. The Antimicrobial Resistance Containment and Surveillance (ARCS) approach provides a framework for public health programs to combat AMR through rational drug use and improved surveillance.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial drug resistance (AMR) poses a significant global public health threat, compromising infectious disease treatments.
  • Previous global strategies, like the WHO's 2001 initiative, have faced challenges in translating recommendations into effective public health actions.

Purpose of the Study:

  • To introduce the Antimicrobial Resistance Containment and Surveillance (ARCS) approach.
  • To facilitate the development of public health programs and resource mobilization for AMR containment.
  • To emphasize the critical link between rational drug use and effective AMR containment strategies.

Main Methods:

  • The ARCS approach integrates clinical management improvements (disease control, diagnostics, treatment, education) with optimized antimicrobial drug supply systems (regulation, essential lists, delivery mechanisms).
  • It defines AMR containment as the continuous application of a core package of interventions.
  • Surveillance of AMR extent, trends, and drug supply/use is integral for monitoring containment progress and outcomes.

Main Results:

  • The ARCS approach provides a structured framework for addressing the complex issue of AMR containment.
  • It highlights the necessity of a multi-faceted strategy involving both clinical practice and drug supply chain management.
  • The ARCS diagram offers a simplified illustration of the containment and monitoring process.

Conclusions:

  • The ARCS approach offers a practical framework for formulating public health programs to contain antimicrobial resistance.
  • Effective containment requires a continuous, integrated strategy focusing on rational drug use, improved clinical practices, and robust surveillance systems.
  • This approach aims to mobilize necessary resources for a coordinated global response to the growing threat of AMR.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...